Medical Robotics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Surgical Robots (Neurosurgical Robots, General surgery Robots, Orthopaedic Surgical Robots, and Robotic-Assisted Endoscopic Devices), Rehabilitation Robots (Assistive Robots, Prosthetic Robots, and Exoskeleton Robots), Hospital & Pharmacy Automation Robots (Medication Dispensing Robots, Telepresence Robots, and Laboratory Robots), Non-invasive Radiosurgery Robots, and Others), By Application (Urology, Cardiology, Gynaecology, Neurosurgery, General Surgery, Orthopaedic Surgery, Rehabilitation & Elderly Care, Radiology & Radiation Therapy, and Pharmacy & Hospital Automation), By Component (Instruments & Accessories, Robotic Systems, and Services), By End User (Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgery Centers (ASCs), and Pharmacies & Laboratories), and Region Forecast 2020-2031

Medical Robotics Market size was valued at US$ XX million in 2024 and is expected to reach US$ XX million by 2031, growing at a significant CAGR of X% from 2025-2031. Moreover, in the USA, the Medical Robotics Market size was valued at US$ xx million in 2024 and is projected to reach US$ xx million by 2031, growing at a CAGR of xx% from 2025-2031. The market refers to the domain of robotic systems, instruments, and services used in healthcare that enable or assist in performing medical procedures with greater precision, control, and efficiency than conventional techniques. These technologies are used in surgery, diagnostics, rehabilitation, patient care, and hospital automation to improve treatment outcomes, reduce risks, shorten recovery, and streamline workflows. Growth is driven by increasing demand for minimally invasive surgeries and continuous innovation in AI, imaging, machine learning, and haptics.

For instance, the company CMR Surgical reported having installed over 100 Versius surgical robotic systems globally and having carried out more than 5,000 clinical cases across many specialties. In India, Apollo Hospitals has achieved a milestone of more than 10,000 robotics-assisted surgeries, with over a 400% increase in robotic procedures over two years. The UK’s NHS performed about 70,000 robot-assisted surgeries in 2023/24, and plans to increase that to 500,000 operations per year by 2035, making robot?assisted techniques the default for many keyhole surgeries. Key trends include miniaturization of devices, expansion of collaborative robots in rehabilitation and patient handling, tele-surgery, and greater emphasis on training and regulatory oversight. Challenges remain high cost of robot platforms, need for specialized training of surgeons and staff, and ensuring safety and regulatory compliance.

Facts & Figures

• GKNM Hospital, Coimbatore performed 150 robotic surgeries in one year.
• Shalby Hospitals, Ahmedabad reported 20% of surgeries are robot-assisted.
• Over 2,000 hospitals in the U.S. utilize robotic surgical systems, reflecting widespread institutional adoption.

Key Takeaways

• The World Health Organization (WHO) and the Society of Robotic Surgery launched a health innovation initiative to expand access to virtual care and telesurgery in underserved regions. This partnership aims to promote equity through telesurgery and health systems innovation.
• Hospitals offering robotic surgeries are increasingly seen as technologically advanced, attracting higher patient volumes and complex surgical cases.
• Beyond precision, robotic systems help hospitals reduce average length of stay and post-operative complications, indirectly cutting costs and improving bed turnover.
• The adoption of robotics encourages integration between surgery, imaging, AI analytics, and rehabilitation teams, creating data-driven, multidisciplinary care pathways that enhance overall patient outcomes.

Key Developments:

• In September 2025, Levita Magnetics announced the world's first AI-guided autonomous surgery with its MARS platform. The system combines magnetic technology with robotics, enabling smaller incisions, fewer instruments, and reduced staffing requirements, ultimately raising standards of care in procedures like bariatric and gallbladder surgeries.
• In July 2025, Zimmer Biomet announced the acquisition of Monogram Technologies for approximately $177 million. This strategic move aims to enhance Zimmer's robotics portfolio, particularly in surgical robotics. Monogram specializes in semi- and fully autonomous surgical technologies, including a semi-autonomous knee replacement system approved by the FDA in March 2025.
• In July 2025, Olympus took a significant equity stake in Swan EndoSurgical with a combined initial investment of at least $65 million. Swan EndoSurgical is developing an innovative endoluminal robotic system for less invasive therapeutic treatments. The total combined funding could reach up to $458 million if pre-agreed milestones are met.
• In March 2025, NYU Langone Health completed a three-year merger with Long Island Community Hospital, now rebranded as NYU Langone Hospital - Suffolk. The merger has led to significant enhancements in services, including the introduction of robotic procedures. The facility has performed over 1,500 robotic procedures, offering benefits like smaller incisions, less bleeding, and faster recovery times.
• In March 2025, Stryker showcased the next generation of its Mako SmartRobotics™ suite with the introduction of Mako Spine and Mako Shoulder applications. The first Mako Spine cases were completed in October 2024, and the full U.S. commercial launch is expected in the second half of 2025.

Medical Robotics Market Segmentation:

Based on the Product Type:

• Surgical Robots
  • Neurosurgical Robots
  • General surgery Robots
  • Orthopaedic Surgical Robots
  • Robotic-Assisted Endoscopic Devices
• Rehabilitation Robots
  • Assistive Robots
  • Prosthetic Robots
  • Exoskeleton Robots
• Hospital & Pharmacy Automation Robots
  • Medication Dispensing Robots
  • Telepresence Robots
  • Laboratory Robots
• Non-invasive Radiosurgery Robots
• Others

Surgical robots dominate the market, driven by their widespread hospital adoption and procedural growth. For instance, Intuitive Surgical reported over 2.3 million da Vinci procedures in 2023 globally, while England’s NHS performed 70,000 robotic-assisted surgeries in 2023/24 (NHS England), underscoring their leadership across specialties.

Based on the Application;

• Urology
• Cardiology
• Gynaecology
• Neurosurgery
• General Surgery
• Orthopaedic Surgery
• Rehabilitation & Elderly Care
• Radiology & Radiation Therapy
• Pharmacy & Hospital Automation

Urology leads the market, with robotic?assisted prostatectomy as the most widely performed procedure. The NHS in England reported over 12,000 prostatectomies in 2023/24, most robot?assisted, reflecting clinical preference. Intuitive Surgical confirms that urology remains the highest?volume specialty for da Vinci systems globally, underscoring its leadership.

Based on the Component:

• Instruments & Accessories
• Robotic Systems
• Services

Instruments & Accessories dominate the market, driven by recurring demand during each surgical procedure. For example, Intuitive Surgical reported over 1.9 million da Vinci instrument and accessory shipments in 2023, generating the bulk of its recurring revenue. (Intuitive Surgical Annual Report 2023). This segment ensures steady, procedure-linked growth.

Based on the End User:

• Hospitals
• Specialty Clinics
• Rehabilitation Centers
• Ambulatory Surgery Centers (ASCs)
• Pharmacies & Laboratories

The hospitals segment dominates the market due to high adoption in surgical procedures. In India, GKNM Hospital in Coimbatore performed 150 robotic surgeries within a year, while Shalby Hospitals in Ahmedabad reported 20% of their surgeries as robot-assisted, highlighting growing hospital reliance on robotic systems.